Selling And Administration Expenses Changement Date
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
Acorda Therapeutics USD 21.82M 689K 2023-06
Amgen USD 1.76B 424M 2023-12
Bayer EUR 3.6B 81M 2023-09
Biogen USD 608.5M 179.7M 2023-12
Brainstorm Cell Therapeutics USD 2.7M 50K 2023-09
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Capricor Therapeutics USD 3.02M 174.11K 2023-09
Cytokinetics USD 44.11M 4M 2023-12
Eisai JPY 92.79B 6.7B 2023-09
Eli Lilly USD 1.92B 120.7M 2023-12
Exelixis USD 138.14M 3.58M 2023-09
Geron USD 21.4M 3.05M 2023-12
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
Intra Cellular Therapies USD 104.72M 487K 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Ligand Pharmaceuticals USD 15.99M 1.34M 2023-12
Merck USD 2.75B 272M 2023-12
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06



Cytokinetics Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.